OFFICE LEASEConfidential Treatment • September 5th, 2013 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This Office Lease (this “Lease”), dated as of the date set forth in Section 1.1, is made by and between BRE/COH OH LLC, a Delaware limited liability company (“Landlord”), and NAVIDEA BIOPHARMACEUTICALS, INC., a Delaware corporation (“Tenant”). The following exhibits are incorporated herein and made a part hereof: Exhibit A (Outline of Premises); Exhibit B (Work Letter); Exhibit C (Form of Confirmation Letter); Exhibit D (Rules and Regulations); Exhibit E ([Intentionally Omitted]); Exhibit F (Additional Provisions); Exhibit F-1 (Form of Letter of Credit); and Exhibit F-2 (Outline of Potential Refusal Space).
